Fleury SA
BOVESPA:FLRY3

Watchlist Manager

Fleury SA

BOVESPA:FLRY3

Watchlist

Dividends

Price: 13.8 BRL -0.86%

Market Cap: 7.5B BRL

Have any thoughts about
Fleury SA?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Estee Lauder Companies Inc NYSE:EL	Consumer products
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Church & Dwight Co Inc NYSE:CHD	Consumer products
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	American Express Co NYSE:AXP	Financial Services
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Target Corp NYSE:TGT	Retail
US	Walt Disney Co NYSE:DIS	Media
US	Mueller Industries Inc NYSE:MLI	Machinery
US	PayPal Holdings Inc NASDAQ:PYPL	Technology

Add Price Alert

Price Target:

Last Price: 13.8 BRL

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

FLRY3 Alert

Fleury SA

13.8

-0.12 (-0.86%)

52 Week Range	13.6 18.58
Price Target

We'll email you a reminder when the closing price reaches BRL.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Estee Lauder Companies Inc NYSE:EL	US
	Exxon Mobil Corp NYSE:XOM	US
	Church & Dwight Co Inc NYSE:CHD	US
	Pfizer Inc NYSE:PFE	US
	American Express Co NYSE:AXP	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Target Corp NYSE:TGT	US
	Walt Disney Co NYSE:DIS	US
	Mueller Industries Inc NYSE:MLI	US
	PayPal Holdings Inc NASDAQ:PYPL	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Fleury SA

What unique competitive advantages
does Fleury SA hold over its rivals?

What risks and challenges
does Fleury SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Fleury SA.

What unique competitive advantages
does Fleury SA hold over its rivals?

What risks and challenges
does Fleury SA face in the near future?

Summarize the latest earnings call
of Fleury SA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Fleury SA.

Provide P/S
for Fleury SA.

Provide P/E
for Fleury SA.

Provide P/OCF
for Fleury SA.

Provide P/FCFE
for Fleury SA.

Provide P/B
for Fleury SA.

Provide EV/S
for Fleury SA.

Provide EV/GP
for Fleury SA.

Provide EV/EBITDA
for Fleury SA.

Provide EV/EBIT
for Fleury SA.

Provide EV/OCF
for Fleury SA.

Provide EV/FCFF
for Fleury SA.

Provide EV/IC
for Fleury SA.

Show me price targets
for Fleury SA made by professional analysts.

What are the Revenue projections
for Fleury SA?

How accurate were the past Revenue estimates
for Fleury SA?

What are the Net Income projections
for Fleury SA?

How accurate were the past Net Income estimates
for Fleury SA?

What are the EPS projections
for Fleury SA?

How accurate were the past EPS estimates
for Fleury SA?

What are the EBIT projections
for Fleury SA?

How accurate were the past EBIT estimates
for Fleury SA?

Compare the revenue forecasts
for Fleury SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Fleury SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Fleury SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Fleury SA compared to its peers.

Compare the P/E ratios
of Fleury SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Fleury SA with its peers.

Analyze the financial leverage
of Fleury SA compared to its main competitors.

Show all profitability ratios
for Fleury SA.

Provide ROE
for Fleury SA.

Provide ROA
for Fleury SA.

Provide ROIC
for Fleury SA.

Provide ROCE
for Fleury SA.

Provide Gross Margin
for Fleury SA.

Provide Operating Margin
for Fleury SA.

Provide Net Margin
for Fleury SA.

Provide FCF Margin
for Fleury SA.

Show all solvency ratios
for Fleury SA.

Provide D/E Ratio
for Fleury SA.

Provide D/A Ratio
for Fleury SA.

Provide Interest Coverage Ratio
for Fleury SA.

Provide Altman Z-Score Ratio
for Fleury SA.

Provide Quick Ratio
for Fleury SA.

Provide Current Ratio
for Fleury SA.

Provide Cash Ratio
for Fleury SA.

What is the historical Revenue growth
over the last 5 years for Fleury SA?

What is the historical Net Income growth
over the last 5 years for Fleury SA?

What is the current Free Cash Flow
of Fleury SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Fleury SA.

EV/S
Enterprise Value to Sales

1.4

Current

1.8

Median

2.5

Industry

Lower than median

Lower than industry value

Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.

EV/S

1.4

Enterprise Value

10.1B BRL

Revenue

7.5B BRL

All Countries

Forward Multiples

			Market Cap	EV/S
BR		Fleury SA BOVESPA:FLRY3	7.5B BRL	1.4
US	C	Cigna Group XMUN:CGN	88.5B EUR	0.5
US		Cigna Corp NYSE:CI	91.4B USD	0.5
US		CVS Health Corp NYSE:CVS	68.5B USD	0.3
DE		Fresenius Medical Care AG XMUN:FME	23.3B EUR	1.7
US		Laboratory Corporation of America Holdings NYSE:LH	20.7B USD	1.9
DE		Fresenius SE & Co KGaA XETRA:FRE	18.6B EUR	1.3
US		Quest Diagnostics Inc NYSE:DGX	18B USD	2.4
US		DaVita Inc NYSE:DVA	12.9B USD	1.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	11.9B EUR	1.1
US		Chemed Corp NYSE:CHE	8.5B USD	3.5


BR		Fleury SA BOVESPA:FLRY3	Average EV/S: 1.5 1.4
US	C	Cigna Group XMUN:CGN	0.5
US		Cigna Corp NYSE:CI	0.5
US		CVS Health Corp NYSE:CVS	0.3
DE		Fresenius Medical Care AG XMUN:FME	1.7
US		Laboratory Corporation of America Holdings NYSE:LH	1.9
DE		Fresenius SE & Co KGaA XETRA:FRE	1.3
US		Quest Diagnostics Inc NYSE:DGX	2.4
US		DaVita Inc NYSE:DVA	1.7
DE	F	Fresenius Medical Care AG & Co KGaA XETRA:FME	1.1
US		Chemed Corp NYSE:CHE	3.5

EV/S Forward Multiples

Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/S

1.3

2-Years Forward

EV/S

1.2

3-Years Forward

EV/S

1.1

Fleury SA
BOVESPA:FLRY3

EV/S
Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Fleury SA BOVESPA:FLRY3

EV/S Enterprise Value to Sales

EV/S Forward Multiples

See Also

Company

Help

Tools

Stocks

Fleury SA
BOVESPA:FLRY3

EV/S
Enterprise Value to Sales